Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Accretive Health, Inc.    AH   US00438V1035

End-of-day quote. End-of-day quote Nyse - 03/17
8.22 USD   +2.49%
04/02 ACCRETIVE HEALTH : Assigned Patent
03/26 ACCRETIVE HEALTH : Assigned Patent
03/19 OTC MARKETS : Accretive Health Common Stock to Commence Trading on the Over..
SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 

Accretive Health, Inc. : Accretive Health Reports Inducement Grant under NYSE Rule 303A.08

04/04/2013 | 07:05am US/Eastern
Recommend:
0

Accretive Health, Inc. (NYSE: AH) today announced that pursuant to the employment agreement entered into with Stephen Schuckenbrock on April 2, 2013, the company granted to Mr. Schuckenbrock on April 3, 2013 a non-qualified stock option under the New York Stock Exchange inducement grant exception. The inducement grant was approved by the company's Board of Directors on April 1, 2013 and is being made as an inducement material to Mr. Schuckenbrock's acceptance of employment with the company, in accordance with New York Stock Exchange Rule 303A.08. The company previously announced that Mr. Schuckenbrock has been appointed President and Chief Executive Officer and a member of the company's Board of Directors, effective April 3, 2013.

The stock option is for the purchase of 2,903,801 shares of the company's common stock, with an exercise price of $9.56, which was the closing price of the company's common stock reported on the New York Stock Exchange on April 3, 2013. The stock option will vest and become exercisable on a ratable monthly basis over 48 months based on continued service to the company, subject to acceleration in specified circumstances.

Accretive Health is providing the above information regarding Mr. Schuckenbrock's inducement grant in accordance with New York Stock Exchange Rule 303A.08.

About Accretive Health

At Accretive Health, our mission is to help our healthcare clients strengthen their financial stability and deliver better care at a more affordable cost to the communities they serve (increasing healthcare access to all). For more information, visit www.accretivehealth.com.

Accretive Health, Inc.
Investor Relations:
Atif Rahim
Telephone: 312.324.5476
email: investorrelations@accretivehealth.com
or
Media:
Puneet Singh
Telephone: 330.565.6802
email: mediarelations@accretivehealth.com


© Business Wire 2013
Recommend :
0
React to this article
Latest news on ACCRETIVE HEALTH, INC.
04/02 ACCRETIVE HEALTH : Assigned Patent
03/26 ACCRETIVE HEALTH : Assigned Patent
03/19 OTC MARKETS : Accretive Health Common Stock to Commence Trading on the Over-The-..
03/14 NYSE stocks posting largest percentage decreases
03/14 ACCRETIVE HEALTH : Regulation FD Disclosure, Notice of Delisting or Failure to S..
03/13 ACCRETIVE HEALTH : NYSE to Suspend Trading in Accretive Health and Commence Deli..
03/12 ACCRETIVE HEALTH, INC. : Accretive Health Provides Restatement Update
02/28 ACCRETIVE HEALTH, INC. : Accretive Health Taps Patrick Funck as CIO
02/24 ACCRETIVE HEALTH, INC. : Patrick Funck Joins Accretive Health as Chief Informati..
01/24 ACCRETIVE HEALTH, INC. : FILES (8-K) Disclosing Costs Associated with Exit or Di..
Advertisement
Chart
Duration : Period :
Accretive Health, Inc. Technical Analysis Chart | AH | US00438V1035 | 4-Traders
Income Statement Evolution
Accretive Health, Inc. : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF